Current Situation and Solutions of Basal Insulin Use in Primary Healthcare Institution in China
In recent years,the country has paid close attention to the service quality of primary medical institutions,but the current situation of basic primary care for diabetes is not satisfactory.This is related to the insufficient understanding of basic insulin in primary healthcare in China.This review starts with the current application status of basal insulin in primary medical institutions in China and the analysis of the reasons for its applicable plight,with a focus on comparing the effectiveness and safety of basal insulin analogues(including insulin degludec and insulin glargine).Based on the introduction of volume-based insulin procurement in recent years,it is hoped that the review will help to rationally select basal insulin and improve blood glucose control in primary medical institutions in China.